Cargando…
Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations
INTRODUCTION: Using genome-wide expression profiles of a prospective training cohort of breast cancer patients, ClinicoMolecular Triad Classification (CMTC) was recently developed to classify breast cancers into three clinically relevant groups to aid treatment decisions. CMTC was found to be both p...
Autores principales: | Wang, Dong-Yu, Done, Susan J, Mc Cready, David R, Leong, Wey L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226941/ https://www.ncbi.nlm.nih.gov/pubmed/24996446 http://dx.doi.org/10.1186/bcr3686 |
Ejemplares similares
-
A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis
por: Wang, Dong-Yu, et al.
Publicado: (2011) -
Clinicomolecular Identification of Conserved and Individualized Features of Granulomatous Uveitis
por: Hassman, Lynn M., et al.
Publicado: (2021) -
Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study
por: Dowling, Ryan JO, et al.
Publicado: (2015) -
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular Assay
por: Soliman, Hatem, et al.
Publicado: (2019) -
Cover's universal portfolio, stochastic portfolio theory, and the numéraire portfolio
por: Cuchiero, Christa, et al.
Publicado: (2018)